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Abstract
Chronic skin conditions, such as atopic eczema and psoriasis, can have significant psychological effects 
on patients. For example, these conditions can affect an individual’s functioning, and may lead to mental 
health issues such as depression or anxiety disorders. This article identifies the links between chronic 
skin conditions and mental health issues, and discusses the nurse’s role in assessing, managing and 
supporting patients with these comorbidities. It also emphasises the importance of using validated tools 
and a holistic approach to care, and discusses how to address challenges that patients may experience.
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The skin is the largest organ in the human 
body and can be affected by a broad range of 
conditions, some of which may be chronic and 
relapsing in nature, for example atopic eczema 
and psoriasis. A five-nation European study 
using a random sample of more than 12,000 
adults indicated that the lifetime prevalence  
rates of physician‐diagnosed skin conditions  
were around 28% for warts, 7% for atopic 
eczema, 5% for psoriasis and 3% for skin  
cancer (Svensson et al 2018).
Skin conditions are a substantial cause of 
disability. In the Global Burden of Disease 
Study 2013, skin and subcutaneous diseases 
were identified as the 18th leading cause of 
global disability-adjusted life years (DALYs) (a 
standard metric used to estimate disease burden) 
(Karimkhani et al 2017), and the fourth leading 
cause of non-fatal disease burden worldwide. 
These conditions can also have significant negative 
effects on people’s quality of life, while some, 
such as skin cancer, may be life‐threatening.
People with chronic skin conditions frequently 
experience psychological challenges that can 
affect their social functioning (Tuckman 2017). 
For example, they may experience fearful 
anticipation of interaction with others, even 
when symptoms are not present, and develop 
avoidance-coping mechanisms. This can 
subsequently prevent these individuals from fully 
participating in social and recreational activities 
or employment (Tuckman 2017). Studies have 
shown that depressive symptoms and reduced 
psychological well-being are associated with 
conditions such as atopic eczema (Smirnova 
et al 2020), and the extent of distress associated 
with atopic eczema appears to be greater than 
that for other long-term conditions (Cheng and 
Silverberg 2019).
In the UK, the All-Party Parliamentary Group 
on Skin (APPGS) (2020) conducted a survey 
to explore the experiences of people with skin 
conditions (n=544), asking them to describe 
how their condition affected their mental 
health. Of the respondents, 98% reported that 
their condition affected their emotional and 
psychological well-being, while 5% reported 
experiencing suicidal thoughts. 
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Why you should read this article:
	● To recognise the psychological effects of chronic skin conditions that patients may experience
	● To refresh your knowledge of the core principles of the assessment and management of mental health issues
	● To identify how you could enhance the care and support of patients with chronic skin conditions in your practice
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The APPGS (2020) report 
expressed concern that access to 
specialist mental health support 
for people with skin conditions is 
limited throughout the UK, despite 
a growing need for such services.
There is a consistent link 
between the experience of skin 
conditions and an increased 
likelihood of mental health issues, 
most commonly depression and 
anxiety disorders (Barankin and 
DeKoven 2002, Jafferany and 
Pastolero 2018). This increased risk 
of comorbid mental health issues 
requires healthcare professionals to 
have sufficient confidence and skills 
to recognise and respond to signs 
of psychological distress, as well as 
to recognise the features of mental 
health issues and indicators of risk 
(APPGS 2020).
This article seeks to clarify 
the links between chronic skin 
conditions and mental health issues, 
and outlines what is involved in the 
assessment, management and care 
of patients with these comorbidities. 
It provides practical guidance for 
nurses in all areas of practice, 
detailing the actions they can take 
to support this patient group.
Chronic skin conditions 
Like other long-term conditions, 
chronic skin conditions are 
characterised by a persistent 
illness course and the requirement 
for ongoing treatment. The time 
course for some of these conditions 
is typified by remission and 
relapse, whereby symptoms may 
disappear for up to several years, 
only to subsequently reappear 
at times of particular stress. 
Rather than a curative approach, 
treatments are used to manage 
the condition’s effects. The two 
most common skin conditions 
that demonstrate this pattern are 
atopic eczema and psoriasis, which 
can be controlled effectively with 
medicines, but where patients can 
also experience acute exacerbations 
(‘flares’) during which their 
condition is worse.
Eczema is characterised by dry 
skin, inflammation and itching. 
The most common form is atopic 
eczema, which usually affects 
children, but can extend into 
adulthood. In addition, there are 
several other forms of eczema 
that may affect older adults, for 
example nummular eczema and 
varicose eczema (Ersser and Van 
Onselen 2010).
Psoriasis is an inflammatory skin 
disease characterised by red patches 
of skin covered by scaly plaques, 
which may be itchy and cause 
bleeding if scratched. It is estimated 
to affect around 1% to 2% of people 
in the UK (National Institute for 
Health and Care Excellence (NICE) 
2017). Although it can occur at any 
age, two peaks in its incidence  
have been identified – one between 
20 years and 30 years of age and the 
other between 50 years and 60 years 
of age (Cohen et al 2012). Psoriasis 
can result in significant impairments 
in a person’s functioning, as well as 
various psychological issues.
Interaction between mental 
health and skin conditions 
Understanding the link between 
mental health and skin conditions 
is important because their 
co-occurrence can result in 
substantially increased disability 
and distress, and may negatively 
affect the course of an individual’s 
skin condition and their response to 
treatment (Barankin and DeKoven 
2002). The link between mental 
health and skin conditions involves 
a complex interaction underpinned 
by a range of mechanisms acting 
as both a cause and consequence 
(Haddad 2010). This means that 
mental health issues can be (Koo 
and Lee 2003):
 » A direct cause of a skin condition 
– that is, a person has a primary 
psychiatric disorder that leads to 
a skin condition.
 » A consequence of a skin 
condition.
 » A factor that influences the 
development and course of  
a skin condition.
There are several primary 
psychiatric disorders that can 
result in skin conditions. For 
example, people with obsessive‐
compulsive disorder (OCD) and 
related disorders – predominantly 
trichotillomania (hair pulling), 
body dysmorphic disorder and 
skin-picking disorder – frequently 
present to dermatologists due to 
associated hair and skin symptoms 
(Mavrogiorgou et al 2015). These 
people are likely to require referral 
to specialist mental health services, 
so this article does not focus on this 
patient group.
This article explores the more 
common situation and pathway, 
in which the clinical features 
and chronic nature of a person’s 
skin condition affect their mood 
and psychological well-being. 
These effects can range from mild 
and fluctuating stress to severe, 
disabling and potentially life-
threatening mental health issues 
(Barankin and DeKoven 2002). In 
addition, psychosocial factors such 
as prolonged stress, depressed mood 
and anxiety can affect a person’s 
inflammatory and immune 
responses (Hall et al 2012), and so 
can influence the development of 
skin conditions and/or exacerbate 
their symptoms. These factors and 
conditions may also influence an 
individual’s behaviour, for example 
by reducing their adherence to 
treatment or leading to unhealthy 
lifestyle choices.
Assessment of mental 
health issues
Fundamental to the effective 
management of chronic skin 
conditions is a holistic assessment 
Box 1. Principles for assessing the mental health 
of patients with chronic skin conditions
 » Assessments conducted by healthcare professionals in primary 
and secondary care should be holistic, addressing psychosocial 
as well physical aspects of the patient’s presentation 
 » It is important to demonstrate empathy, particularly because 
perceptions of stigmatisation are common among people with 
a visible skin condition and may exert a strong negative effect 
on their quality of life 
 » As with other chronic physical health conditions, when 
assessing a patient with a skin condition, be alert to the 
presence of mental health issues – particularly depression  
and anxiety disorders
 » Review the patient’s history to identify any previous mental 
health issues
 » Where depression or anxiety are suspected, initially use an 
appropriate brief screening tool such as the Patient Health 
Questionnaire-2 (PHQ-2) (Kroenke et al 2003) or the Generalised 
Anxiety Disorder-2 (GAD-2) (Kroenke et al 2007)
 » When conducting a full mental health assessment, use 
appropriate validated tools, such as the PHQ-9 (Kroenke et al 
2001) for depression or the GAD-7 (Spitzer et al 2006). These tools 
can inform the assessment and assist in treatment evaluation 
 » When a mental health issue is evident, it is crucial to assess 
the patient’s suicidal ideation and intent. If a risk of self-harm or 
suicide is identified, assess the adequacy of social support and 
the patient’s awareness of sources of support. Arrange support 
appropriate to their level of risk
(National Institute for Health and Care Excellence 2009, 2011, Ghosh et al 2013, 
All-Party Parliamentary Group on Skin 2020)
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that addresses the psychosocial 
aspects of an individual’s history 
and presentation. Understanding the 
effects that a chronic skin condition 
has on an individual requires 
a holistic assessment because it 
cannot be assumed that the effects 
of the condition on a person’s 
mental health are directly related to 
disease severity. 
Blanco et al’s (2019) study 
examined the relationships 
between disease severity and 
illness perceptions in 211 patients 
with hidradenitis suppurativa – 
a painful chronic inflammatory 
skin condition characterised by 
nodules and pustulent abscesses, 
often leading to open wounds that 
are challenging to heal. Blanco 
et al (2019) found that patients’ 
psychological well-being was 
much more closely associated 
with the patient’s beliefs about 
their condition than healthcare 
professionals’ assessments of 
disease severity. Thus, what may 
be perceived as a mild condition 
by a healthcare professional 
could have severe psychological 
effects on the patient (Blanco et al 
2019). Box 1 outlines some of the 
principles for assessing the mental 
health of patients with chronic 
skin conditions.
Various tools have been developed 
to assist in the objective assessment 
of a person’s mental health, and 
these are reviewed and described 
in the NICE (2011) guidance in 
greater detail. This article describes 
some of the principles of assessment 
and tools used for depression and 
anxiety disorders, since these are 
the most common mental health 
issues experienced by people with 
chronic skin conditions (Barankin 
and DeKoven 2002, Jafferany and 
Pastolero 2018).
Depression
Depression is a common and 
disabling mental health issue that 
affects around one in six people 
over the course of a lifetime 
(Bromet et al 2011). Its core 
features are persistent low mood 
and a loss of enjoyment or interest 
in activities and experiences, which 
may be accompanied by a range 
of associated emotional, cognitive, 
physical and behavioural symptoms, 
for example sleep disturbances, 
changes in appetite, reduced 
energy, feelings of guilt and/or 
worthlessness, and suicidal thoughts 
(NICE 2009).
The risk of experiencing 
depression is substantially 
increased among people with any 
chronic physical health condition, 
with reviews identifying that 
its prevalence is approximately 
doubled in people with diabetes 
mellitus, hypertension, coronary 
artery disease and heart failure 
compared with healthy controls 
(NICE 2009). This elevated risk is 
evident for chronic skin conditions 
such as psoriasis (Dowlatshahi 
et al 2014). 
An extensive evaluation of more 
than 100 studies found that several 
tools are effective in identifying 
depression in people with chronic 
physical health conditions (Meader 
et al 2011). One of these tools is 
the Patient Health Questionnaire-9 
(PHQ-9) (Kroenke et al 2001), 
which is widely used in primary 
care services in the UK, has good 
psychometric characteristics and 
has been found to be feasible and 
acceptable as an assessment tool 
for patients with comorbid physical 
health conditions. However, rather 
than asking every question on 
the PHQ-9, nurses can use the 
brief PHQ-2 (Kroenke et al 2003) 
screening tool. 
The PHQ-2 has been found 
to have excellent sensitivity for 
detecting depression, and it has been 
suggested to be the preferred method 
for quickly assessing depression 
(Meader et al 2011). It is also 
the recommended initial tool for 
assessing depression in people with 
chronic physical health conditions 
(NICE 2009). The PHQ-2 comprises 
the first two questions of the PHQ-9, 
which require a yes or no response 
from the patient:
 » During the last month, have you 
often been bothered by feeling 
down, depressed or hopeless?
 » During the last month, have 
you often been bothered by 
little interest or pleasure in 
doing things?
A positive response to either or 
both of these questions indicates 
depression may be likely, and 
a thorough mental health 
assessment is required. If it is 
beyond the limits of the nurse’s 
competence to perform such an 
assessment, the patient should 
be referred to an appropriate 
healthcare professional (NICE 
2009). Box 2 describes what is 
involved in performing a mental 
health assessment in patients with 
suspected depression.
Anxiety disorders
One of the most prevalent types 
of anxiety is generalised anxiety 
disorder (GAD). The core feature of 
GAD is excessive anxiety and worry 
about several events or activities, 
which occurs more days than not 
for a period of at least six months 
(NICE 2011). Unlike in phobic 
anxiety disorders, the symptoms of 
GAD are not focused on specific 
events or activities, and they may 
be accompanied by restlessness, 
fatigue, concentration issues, 
irritability, muscle tension and sleep 
disturbances (NICE 2011).
Nurses should be aware that 
having a chronic skin condition is 
a potential risk factor for anxiety 
disorders (NICE 2011). Where 
a person appears to be experiencing 
somatic features of anxiety, such 
as muscle aches, insomnia and 
sweating, or may be at risk of GAD, 
the nurse should use an appropriate 
brief screening tool such as the 
GAD-2 (Kroenke et al 2007).
The GAD-2 is a brief two-
item scale that comprises the 
Key points
	● Examples of chronic skin conditions include 
atopic eczema and psoriasis
	● Mental health issues can be a direct cause of 
a skin condition, a consequence of having a 
skin condition, or a factor that influences the 
development and course of a skin condition
	● To manage chronic skin conditions effectively, 
it is essential to undertake a holistic 
assessment that incorporates the psychosocial 
aspects of a person’s history and presentation
	● The ability to clearly communicate the 
associations between mental health, stress, 
and the development and course of skin 
conditions remains an important aspect of 
patient education, and can inform approaches 
to improve condition self-management
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first two statements of the longer 
GAD-7 (Spitzer et al 2006) scale. 
The GAD-2 has been extensively 
evaluated and found to have 
high sensitivity and specificity 
for GAD (NICE 2011). It also 
performs adequately as a screening 
tool for other common anxiety 
disorders, such as panic disorder, 
social anxiety disorder and post-
traumatic stress disorder (PTSD) 
(Kroenke et al 2007). In the 
GAD-2, the patient scores each of 
the following statements on a scale 
of 0 (not at all) to 3 (nearly every 
day) according to their frequency 
over a two-week period (Kroenke 
et al 2007):
 » Feeling nervous, anxious or 
on edge. 
 » Not being able to stop or control 
worrying.
If the patient scores three or 
more on the GAD-2, the nurse 
should consider the possibility 
of an anxiety disorder. If it is 
within the limits of the nurse’s 
competence, they can then perform 
a full assessment for anxiety 
disorders; if not, the person should 
be referred to an appropriate 
healthcare professional for this 
(NICE 2011). If the patient 
scores less than three, but the 
nurse is still concerned about the 
possibility of an anxiety disorder, 
they should ask the following 
question: ‘Do you find yourself 
avoiding places or activities and 
does this cause you problems?’. 
If the person answers yes to this 
question, an anxiety disorder 
should be considered and a full 
assessment should be conducted 
to determine the number, severity 
and duration of their symptoms, as 
well as the degree of distress and 
functional impairment that they 
are experiencing (NICE 2011). 
The seven-item GAD-7 (Spitzer 
et al 2006) scale is a valid tool 
that can be used as part of this full 
assessment (NICE 2011). 
Assessing suicide risk
If a mental health issue has been 
identified during an assessment, 
it is necessary to determine the 
person’s risk of suicide. Suicidal 
thoughts are relatively common 
among people with depression and 
other mental health issues, and 
the nurse should ask sensitive but 
clear questions to examine such 
thoughts and any suicidal intention. 
The assessment should also include 
signposting the availability of social 
support and awareness of other 
sources of support, and ensuring 
that the patient knows what to do 
if the situation deteriorates.
The extent of the person’s risk of 
suicide will determine the nurse’s 
response. Where there is immediate 
or considerable suicide risk – for 
example if a person describes clear 
intentions, has made a plan or 
has a history of suicide attempts 
– urgent referral to specialist 
mental health services is required 
(NICE 2011). 
If the nurse has concerns but 
is uncertain about the most 
appropriate approach to take, 
they need to discuss this with 
their colleagues immediately to 
determine how to address any 
risks and prevent harm. It is also 
important that the findings of the 
risk assessment are documented 
clearly in the patient’s records. 
Management of mental 
health issues
The approaches used to address 
mental health issues in people with 
chronic skin conditions are similar 
to the evidence-based approaches 
used for people with mental 
health issues without a comorbid 
condition. One principle that guides 
care is shared decision-making, in 
which a patient’s care and treatment 
is based on a full discussion of 
their preferences, based on the 
available options and their past 
experiences of treatment. This 
should be used in combination with 
a stepped-care approach, where the 
intensity of care provided is based 
on the severity of people’s mental 
health issues.
Low-intensity psychological 
interventions for mental health 
issues are based on a detailed 
assessment, and they include 
guided self-help, exercise, 
psychoeducation and peer support 
groups (NICE 2009, 2011). These 
may be provided and coordinated 
by the multidisciplinary team in 
primary or secondary care, and 
may involve services such as local 
Improving Access to Psychological 
Therapies (IAPT). Patients should 
also be informed of relevant support 
groups, as well as other local and 
national resources.
Higher-intensity psychological 
interventions involve individual 
and group psychological treatments 
such as cognitive behavioural 
therapy (CBT). In CBT, an 
individual works collaboratively 
with a therapist to identify the 
effects of their thoughts, beliefs 
and interpretations on the 
symptoms, feelings and issues they 
are currently experiencing (NICE 
2011). Antidepressants, such 
as selective serotonin reuptake 
inhibitors, have been found to be 
effective treatments for depression 
and anxiety disorders for people 
with comorbid physical health 
conditions (NICE 2011).
Nurses can provide patient 
education on the role of stress in 
exacerbating skin conditions. For 
example, stress has been reported to 
influence the onset and progression 
of psoriasis (Barankin and DeKoven 
2002). Therefore, it may be useful 
to provide advice on reducing 
stress through techniques such as 
deep breathing.
Challenges for patients
Getting their voice heard
People with chronic skin conditions 
need to cope with the physical 
discomfort this brings and the 
psychological burden associated 
with how it makes them feel. 
This may be compounded by the 
condition’s effects on their social 
Box 2. Performing a mental health assessment 
in patients with suspected depression
A healthcare professional who is competent to perform a mental 
health assessment should: 
 » Ask three further questions to improve the accuracy of the 
assessment of depression: 
 – During the last month, have you often been bothered by 
feelings of worthlessness? 
 – During the last month, have you often been bothered by 
poor concentration?
 – During the last month, have you often been bothered by 
thoughts of death? 
 » Review the patient’s mental state and associated functional, 
interpersonal and social issues
 » Consider the role of the chronic physical health condition and 
any prescribed medicines in the development or maintenance 
of the patient’s depression
 » Ascertain that the optimal treatment for the patient’s physical 
health condition is being provided and adhered to, seeking 
specialist advice if necessary
(National Institute for Health and Care Excellence 2009)
FURTHER 
RESOURCES






© RCN Publishing Company Limited 2021nursingstandard.com
|  PEER-REVIEWED |
relationships, employment and 
finances. Nurses should take 
a holistic approach to supporting 
patients with chronic skin 
conditions, acknowledging the 
importance of treating physical 
symptoms and the psychological 
effects that these symptoms have on 
the patient.
As with many chronic conditions, 
this approach should start with the 
nurse listening to the patient’s story 
and using open-ended questions 
to explore their experiences. 
The expertise that the patient brings 
regarding their condition should 
be acknowledged and respected, 
developing a plan of care that 
reflects this (Coulter et al 2015). 
For example, when describing how 
to use topical treatments, the nurse 
should assess what has been used 
before and whether it has had any 
benefit on the condition.
If the patient reports no benefit, 
the nurse should check whether 
the topical treatment was used 
correctly, or whether the treatment 
was too challenging to incorporate 
into the patient’s daily life. If such 
issues are raised, the nurse should 
consider amending the treatment 
if possible.
Accessing care at the right time
Timely diagnosis and effective 
interventions are essential to 
optimise patient outcomes and 
minimise the negative psychological 
effects of living with a chronic 
skin condition. Therefore, in 
addition to providing ongoing 
medical treatment and care, 
access to psychological and 
educational support should 
be ensured. This support will 
typically entail providing patient 
education and information on 
simple psychological techniques 
to manage symptoms such as 
itching, scratching and sleep 
disturbances. 
A Cochrane review evaluated 
the findings of ten randomised 
controlled trials of psychological 
and/or educational interventions 
used to manage children with atopic 
eczema (Ersser et al 2014). It found 
some evidence that educational 
interventions can lead to reduced 
atopic eczema severity and 
improvements in quality of life, and 
that the use of relaxation methods 
may also reduce the severity of 
the condition.
Adhering to dermatological 
treatments
Chronic skin conditions that are 
mild or moderate in severity are 
generally managed by topical 
therapies, including emollients and 
topical corticosteroids. Patients 
with moderate or severe disease 
severity are more likely to be 
prescribed systemic therapies such 
as phototherapy, methotrexate 
or biologic medicines. However, 
evidence has demonstrated that 
adherence to treatment for skin 
conditions is low (Finlay 2017). 
There are several practical 
factors that may affect patients’ 
adherence to dermatological 
treatments, including:
 » Topical and systemic treatments 
may take several weeks to 
show an effect. Having to 
apply a topical preparation 
for 2-3 weeks before seeing 
any positive outcomes requires 
a commitment from the 
patient, as well as a belief that 
their condition will improve as 
a result.
 » Applying topical preparations is 
time consuming. For example, 
a patient with atopic eczema 
will need to apply an emollient 
at least twice per day and 
often more frequently. When 
experiencing an acute flare, 
they will need to use a topical 
corticosteroid daily and, 
depending on the location of 
the eczema on their body, this 
could be two different topical 
corticosteroids, such as one for 
the body and a less potent one 
for the face. If atopic eczema is 
on their scalp, this will involve 
a third topical preparation. In 
addition, if the patient is paying 
for their prescriptions, these 
treatments will be expensive.
 » Topical preparations are 
often messy. While there have 
been improvements in topical 
preparations, they are still 
frequently greasy and not easy 
to use as part of a normal self-
care regimen. For example, 
applying a greasy emollient 
before getting dressed can feel 
unpleasant and leave marks 
on clothing.
 » Systemic treatments can have 
unwanted side effects, including 
making the condition worse before 
improvements are seen. Ongoing 
blood monitoring will be required 
for many treatments, such as 
methotrexate used to treat severe 
psoriasis, and some treatments, 
such as phototherapy, will require 
patients to attend 2-3 hospital 
appointments per week over  
a ten-week period.
Nurses need to be aware of these 
potential barriers to treatment 
and address them where possible. 
However, one systematic review by 
Vangeli et al (2015) acknowledged 
that while practical factors may 
influence patients’ adherence to 
treatment, psychosocial factors 
were the strongest determinants 
of adherence. These psychosocial 
factors included the relationship 
between the patient and healthcare 
professional, perceptions of treatment 
concerns, and depression. Therefore, 
developing effective relationships 
with patients, considering their 
mental health and well-being, and 
supporting them to develop the 
skills necessary to adhere to their 
treatment, are all important in 
achieving optimal patient outcomes.
Conclusion
Chronic skin conditions are 
relatively common and often 
disabling, so nurses and other 
healthcare professionals are 
likely to encounter patients with 
such conditions in both general 
and specialist settings. These 
conditions are also associated with 
an increased risk of depression 
and anxiety disorders, and less 
commonly with primary psychiatric 
disorders. Therefore, those involved 
in the assessment and care of 
people with chronic skin conditions 
should be alert to the likelihood of 
mental health issues arising in this 
patient group, as well as confident 
in screening for such issues and 
making referrals to specialist 
services where appropriate. 
The ability to clearly 
communicate the associations 
between mental health, stress, and 
the development and course of skin 
conditions remains an important 
part of patient education, and can 
inform approaches to improve 
condition self-management.
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